Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8553780 | 0.83 | NPC1 (0.36) | LMNAKMT2ANPC1NFKB1RAB9A | |
| SCHEMBL8603712 | 0.82 | NR1I2 (0.37) | LMNAKMT2AMAPTNPC1NFKB1 | |
| SCHEMBL8661865 | 0.80 | NPC1 (0.34) | LMNAKMT2AMAPTNPC1NFKB1 | |
| SCHEMBL8604570 | 0.79 | HDAC6 (0.38) | KMT2ANPC1NFKB1RAB9ANFKB2 | |
| SCHEMBL9090532 | 0.79 | KMT2A (0.34) | LMNAKMT2ANPC1NFKB1RAB9A | |
| SCHEMBL8553057 | 0.79 | KMT2A (0.34) | LMNAKMT2ANPC1NFKB1RAB9A | |
| SCHEMBL8551826 | 0.79 | FFAR4 (0.44) | KMT2A | |
| SCHEMBL8553434 | 0.78 | MEN1 (0.36) | LMNAKMT2ANPC1NFKB1RAB9A | |
| SCHEMBL8553882 | 0.78 | HDAC6 (0.37) | KMT2ANPC1NFKB1RAB9ANFKB2 | |
| SCHEMBL8555533 | 0.77 | KMT2A (0.32) | LMNAKMT2ANPC1NFKB1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5846986-A | Therapeutic phenoxyalkylazoles and phenoxyalkylazines | SANOFI (FR) | 1998-12-08 | — | — | US | disclosed |
| US-5721261-A | TREATING PICORNAVIRUS INFECTIONS | SANOFI PHARMACEUTICALS, INC. (US) | 1998-02-24 | — | — | US | disclosed |
| US-5552420-A | TREATING PICORNAVIRAL INFECTIONS | STERLING WINTHROP INC. (US) | 1996-09-03 | — | — | US | disclosed |
| WO-1995031452-A1 | THERAPEUTIC PHENOXYALKYLAZOLES AND PHENOXYALKYLAZINES | SANOFI WINTHROP, INC. (US) | 1995-11-23 | — | — | WO | disclosed |